These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23029549)

  • 1. Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.
    Son NH; Ananthakrishnan R; Yu S; Khan RS; Jiang H; Ji R; Akashi H; Li Q; O'Shea K; Homma S; Goldberg IJ; Ramasamy R
    PLoS One; 2012; 7(9):e46549. PubMed ID: 23029549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central role for aldose reductase pathway in myocardial ischemic injury.
    Hwang YC; Kaneko M; Bakr S; Liao H; Lu Y; Lewis ER; Yan S; Ii S; Itakura M; Rui L; Skopicki H; Homma S; Schmidt AM; Oates PJ; Szabolcs M; Ramasamy R
    FASEB J; 2004 Aug; 18(11):1192-9. PubMed ID: 15284219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.
    Abdillahi M; Ananthakrishnan R; Vedantham S; Shang L; Zhu Z; Rosario R; Zirpoli H; Bohren KM; Gabbay KH; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H297-308. PubMed ID: 22661511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.
    Burkart EM; Sambandam N; Han X; Gross RW; Courtois M; Gierasch CM; Shoghi K; Welch MJ; Kelly DP
    J Clin Invest; 2007 Dec; 117(12):3930-9. PubMed ID: 18037994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
    Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
    Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
    Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
    FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte specific peroxisome proliferator-activated receptor-α overexpression leads to irreversible damage in ischemic murine heart.
    Duerr GD; Heinemann JC; Arnoldi V; Feisst A; Kley J; Ghanem A; Welz A; Dewald O
    Life Sci; 2014 May; 102(2):88-97. PubMed ID: 24657893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
    Ananthakrishnan R; Kaneko M; Hwang YC; Quadri N; Gomez T; Li Q; Caspersen C; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H333-41. PubMed ID: 19060123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched chain amino acids exacerbate myocardial ischemia/reperfusion vulnerability via enhancing GCN2/ATF6/PPAR-α pathway-dependent fatty acid oxidation.
    Li Y; Xiong Z; Yan W; Gao E; Cheng H; Wu G; Liu Y; Zhang L; Li C; Wang S; Fan M; Zhao H; Zhang F; Tao L
    Theranostics; 2020; 10(12):5623-5640. PubMed ID: 32373236
    [No Abstract]   [Full Text] [Related]  

  • 12. PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.
    Son NH; Yu S; Tuinei J; Arai K; Hamai H; Homma S; Shulman GI; Abel ED; Goldberg IJ
    J Clin Invest; 2010 Oct; 120(10):3443-54. PubMed ID: 20852389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
    Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
    Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-specific expression of the tetracycline transactivator confers increased heart function and survival following ischemia reperfusion injury.
    Elsherif L; Wang X; Grachoff M; Wolska BM; Geenen DL; O'Bryan JP
    PLoS One; 2012; 7(1):e30129. PubMed ID: 22272284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.
    Yamaoka T; Nishimura C; Yamashita K; Itakura M; Yamada T; Fujimoto J; Kokai Y
    Diabetologia; 1995 Mar; 38(3):255-61. PubMed ID: 7758869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice.
    Vedantham S; Noh H; Ananthakrishnan R; Son N; Hallam K; Hu Y; Yu S; Shen X; Rosario R; Lu Y; Ravindranath T; Drosatos K; Huggins LA; Schmidt AM; Goldberg IJ; Ramasamy R
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1805-13. PubMed ID: 21636809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity.
    Dewald O; Sharma S; Adrogue J; Salazar R; Duerr GD; Crapo JD; Entman ML; Taegtmeyer H
    Circulation; 2005 Jul; 112(3):407-15. PubMed ID: 16009788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing Cardiac Triacylglycerol Metabolism Improves Recovery From Ischemic Stress.
    Kolwicz SC; Liu L; Goldberg IJ; Tian R
    Diabetes; 2015 Aug; 64(8):2817-27. PubMed ID: 25858561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury.
    Ananthakrishnan R; Li Q; Gomes T; Schmidt AM; Ramasamy R
    Exp Gerontol; 2011 Sep; 46(9):762-7. PubMed ID: 21600277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.
    Vikramadithyan RK; Hu Y; Noh HL; Liang CP; Hallam K; Tall AR; Ramasamy R; Goldberg IJ
    J Clin Invest; 2005 Sep; 115(9):2434-43. PubMed ID: 16127462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.